MoonLake Immunotherapeutics
MLTX • NASDAQ
MoonLake Immunotherapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jorge Santos da Silva, with a market cap of $1.2B.
Market Cap$1.2B
Employees50.0
CEOJorge Santos da Silva
CountrySwitzerland
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
MoonLake Immunotherapeutics FAQ
Common questions about MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open.
MoonLake Immunotherapeutics has approximately 50 employees.